Podcasts about clinical integration

In this episode, Dr. Tim Johnson, VP of Clinical Integration at SSM Health, shares how the system scaled value-based care to over 600,000 lives. He discusses the role of leadership, data infrastructure, and regional differentiation in building a sustainable model that balances value-based and fee-for-service care.

In this episode, Dr. Tim Johnson, VP of Clinical Integration at SSM Health, shares how the system scaled value-based care to over 600,000 lives. He discusses the role of leadership, data infrastructure, and regional differentiation in building a sustainable model that balances value-based and fee-for-service care.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QJY865. CME/MOC/NCPD/AAPA credit will be available until May 13, 2026.Navigating the Clinical Integration of TROP2-Targeted ADCs in TNBC and HR+, HER2- Metastatic Breast Cancer: A Customized Learning Journey In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QJY865. CME/MOC/NCPD/AAPA credit will be available until May 13, 2026.Navigating the Clinical Integration of TROP2-Targeted ADCs in TNBC and HR+, HER2- Metastatic Breast Cancer: A Customized Learning Journey In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QJY865. CME/MOC/NCPD/AAPA credit will be available until May 13, 2026.Navigating the Clinical Integration of TROP2-Targeted ADCs in TNBC and HR+, HER2- Metastatic Breast Cancer: A Customized Learning Journey In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QJY865. CME/MOC/NCPD/AAPA credit will be available until May 13, 2026.Navigating the Clinical Integration of TROP2-Targeted ADCs in TNBC and HR+, HER2- Metastatic Breast Cancer: A Customized Learning Journey In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

Sarah Burge, Director of Clinical Integration at CRUK Cambridge Centre, Illumina's Alison Shelley, Natasha Robertson, Corporate Partnerships Manager, Addenbrooke's Charitable Trust (ACT) tell Julian about their involvement in the Cambridge […]

February 20, 2025: Dr. Alistair Erskine, Enterprise CIO and CDO of Emory Healthcare, explores the unique fusion of university and healthcare IT at Emory, challenging conventional wisdom about institutional separations. As we delve into innovative approaches to leadership, including streaming rounds and trickle feedback systems, how might these methods reshape organizational culture in healthcare? Through fascinating anecdotes from building a hospital in Qatar with unlimited resources to implementing enterprise-wide ambient listening technology, what lessons emerge about innovation when traditional constraints are removed?Key Points:01:04 Combining University and Healthcare IT07:54 Rounding and Student Tech Support15:35 Lessons from Qatar: Building a Hospital21:44 Ambient Listening and AI in Healthcare30:58 Trickle Feedback and Organizational CultureSubscribe: This Week HealthTwitter: This Week HealthLinkedIn: This Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Do gun violence prevention programs work? Why is my doctor asking if I own guns? Why are doctors asking about guns? How can doctors help with gun safety? Our guest Chethan Sathya, MD, director of the Center for Gun Violence Prevention at Northwell Health, joins to discuss the critical issue of gun safety and how hospitals can use a strategic framework that includes community engagement, research, policy development, clinical integration, and medical education. Dr. Sathya emphasizes the importance of screening patients for gun violence risk and how the AMA is advocating for firearm violence prevention to create impactful change. American Medical Association CXO Todd Unger hosts.

Joining us on Well Said is Dr. Philip Solomon, Geriatrics Fellowship Program Director at Northwell Health, Director of Geriatric Education and Clinical Integration, and Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell to discuss the difficulties faced by those needing to be on many different medications at once.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CJD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until April 24, 2025.Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration Approaches In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Astellas and Pfizer, Inc., Exelixis, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CJD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until April 24, 2025.Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration Approaches In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Astellas and Pfizer, Inc., Exelixis, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CJD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until April 24, 2025.Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration Approaches In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Astellas and Pfizer, Inc., Exelixis, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CJD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until April 24, 2025.Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration Approaches In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Astellas and Pfizer, Inc., Exelixis, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CJD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until April 24, 2025.Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration Approaches In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Astellas and Pfizer, Inc., Exelixis, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CJD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until April 24, 2025.Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration Approaches In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Astellas and Pfizer, Inc., Exelixis, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

CME credits: 1.00 Valid until: 12-11-2024 Claim your CME credit at https://reachmd.com/programs/cme/experts-on-the-ground-new-data-and-practical-clinical-integration-of-therapies-approved-for-igan/24046/ Expert Nephrologist Pietro Canetta, MD, MS, gives an overview of top abstracts from Kidney Week 2023 and new therapies for IgAN.=

Join us for an insightful conversation with Steven Carson, Vice President of Clinical Integration at Temple Center for Population Health, Temple University Health System. Steven shares insights on quality improvement efforts pre- and post-pandemic, successful strategies in population health, and effective community partnerships. Tune in for valuable perspectives on enhancing patient outcomes and experiences.

Join us for an insightful conversation with Steven Carson, Vice President of Clinical Integration at Temple Center for Population Health, Temple University Health System. Steven shares insights on quality improvement efforts pre- and post-pandemic, successful strategies in population health, and effective community partnerships. Tune in for valuable perspectives on enhancing patient outcomes and experiences.

In this Better Edge podcase episode, Joshua Meeks, MD, PhD, the Edward M. Schaeffer, MD, PhD, Professor of Urology, sits down with Song Jiang, MD, PhD, a new member of Urologic Oncology at Northwestern Medicine's Central DuPage Hospital. Dr. Meeks and Dr. Jiang discuss advanced therapies in the management of bladder cancer, and how Northwestern Medicine's integration efforts are extending leading-edge treatments and clinical trials past Chicago, to the west and beyond.

Welcome to a captivating episode featuring Drew Contreras, VP of Clinical Integration and Innovation at APTA, as we journey through the evolving landscape of physical therapy. This discussion is a deep dive into the significant trends and technologies shaping the future of the profession in 2024 and beyond.In this episode, you'll discover:The Impact of Digital Health Platforms: How these platforms are reshaping the way physical therapists connect with and treat patients, backed by significant investments and technological advancements.The Role of AI in Physical Therapy: A comprehensive look at how artificial intelligence is supplementing the work of physical therapists by enhancing efficiency and patient outcomes.Human Performance and PT's Expanding Scope: Insights into how physical therapists are increasingly becoming integral parts of human performance teams, offering a unique blend of traditional medical knowledge and cutting-edge practices.Quantifying PT's Value in Healthcare: An exploration of new studies demonstrating the economic benefits and cost-effectiveness of physical therapy interventions.This episode is essential listening for physical therapists, healthcare practitioners, and anyone interested in the dynamic intersection of technology and healthcare. Tune in to stay informed about the latest developments and prepare for the future of physical therapy.Subscribe to our podcast for more insightful episodes on healthcare innovation and the evolving world of physical therapy.

We are taking a break this week but wanted to make sure if you haven't heard this episode yet, you definitely should!Vice President of Clinical Integration and Innovation at the American Physical Therapy Association Drew Contreras stops by to talk all things artificial intelligence within the Physical Therapy and Rehab space!Some of what we talk about:Drew's background and his experience as a physical therapist assigned to the White HouseShould PT's be worried about A.I. taking their jobs?The current state of A.I. and it's possible futureBrought to you by RaintreeProduced by Connversa Hosted on Acast. See acast.com/privacy for more information.

Our guest David Velsor, is an expert in the evolving field of medical fitness. David is the Director of the UMC Health and Wellness Center, and during this episode, he shares his wealth of knowledge and experience, shedding light on the exciting developments and transformations happening in the world of healthcare-integrated fitness.Medical fitness, as David explains, is more than just exercise; it's a holistic approach that merges clinical expertise with fitness regimens to enhance the well-being of patients and clients. The episode delves into various aspects of this rapidly evolving sector, offering valuable insights for fitness professionals, healthcare providers, and anyone intrigued by the intersection of healthcare and fitness.Highlighted topics in the episode included:The Importance of Clinical Integration within Fitness ProgramsThe Changing Role of Personal TrainersFinancial Considerations in the Field of Medical FitnessThe Future of Medical FitnessConnect with our guest David Velsor at: https://www.linkedin.com/in/david-velsor-ms-cep-7a515019b/Connect with us

Vice President of Clinical Integration and Innovation at the American Physical Therapy Association Drew Contreras stops by to talk all things artificial intelligence within the Physical Therapy and Rehab space!Some of what we talk about:Drew's background and his experience as a physical therapist assigned to the White HouseShould PT's be worried about A.I. taking their jobs?The current state of A.I. and it's possible futureBrought to you by RaintreeProduced by Connversa Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Move to Value Podcast we catch up with Colleen Hole, Vice President of Clinical Integration in Population Health at Atrium Health to learn about the new partnership with the retailer Best Buy, the impact of the merger of Atrium Health and Advocate Aurora Health on the Hospital at Home program and Colleen's experience as a presenter at the global Hospital at Home Congress held in Barcelona Spain.You know, the last time we talked, we talked about the Hospital at Home program, and you gave some great information. A back story. And so, how's it going? Is it still a benefit to the community? Is it still being used in the ways that it's supposed to be? I mean, how is it? How are things transpiring?I would say we're continuing to gain momentum in the program. So, as we talked about several weeks ago, it was born out of the COVID crisis if you will. For that, I am grateful for the pandemic because in most large somewhat risk averse organizations these things don't happen very easily. You tend to meet and meet and meet and then finally maybe put together a proforma and do a small pilot. We bypassed all of that. We did a big pilot, um, out of necessity. So, what we're doing now really is pivoting from COVID, which is now less than 10% of our patients, to other diagnoses which I think I mentioned last time: heart failure, COPD, various infections, but then going into oncology, neurology, surgical trauma. Other patient categories that even some established programs I think are not pursuing. Bottom line is we've not been diagnosis specific in this program. We've been more general clinical eligibility first, by clinical condition, and then what diagnosis fit in it. And then obviously once we've got a clinical clearance, you got to look at the social determinant of health and all social determinants of health and all those other factors that play into whether the patient would be successful. But no, it's going great. We have every intention to scale as far as we need to scale to continue to decompress our hospitals. And, your point, it is making a difference in the community. We get a lot of letters and feedback from patients that say please don't ever make me go back to the hospital, I was so much more comfortable here, I feel safe here, I got to be with my dog. You know, that sounds small but it's not small. So again, as we find our population aging with more and more chronic conditions in their senior years, hospitals can be pretty risky places for those patients who are often disoriented, tend to fall at a higher rate, they're at risk for infections, they don't typically eat as well, sleep as well, and they don't move. They tend to stay in their bed with the door shut. Who wants to go down the hall in a hospital gown? So, all of these reasons in most cases make the home a better place for healing.So, we got some big news that hit the media about the partnership with Best Buy and Advocate Health Atrium. How did this come about and how does it work? It's fascinating.Two very large health systems coming together to be one. And looking for the synergies that happen when you do that. Now there are naysayers out there that say stop the madness, health systems shouldn't be merging. They are in Milwaukee, Chicago Illinois market. We're down here in the South, in North Carolina, South Carolina, Georgia, and a tad bit of Alabama. So, we're not in, you know, competing overlapping markets. They're almost identical in size.So let me back up a tad. Advocate and Aurora merged four years ago to become Advocate Aurora. Now that has merged with Atrium Health. So, the national name is Advocate Health, but each market will retain their brand that is known in that community. So, we're still Atrium Health. What I've been involved in is just integration work around nursing. So, how do we align nursing around standards both...

Dr. John Neil is the Executive Vice President and Chief Physician Executive and Network Strategy Officer for HonorHealth in Scottsdale, Arizona. Dr. Neil drives physician engagement throughout HonorHealth, working to ensure that physicians have input and involvement in the decision-making processes of the healthcare system. His work with clinical teams focuses on strategic initiatives, operations, clinical services and the continuum of patient care.An interventional radiologist by clinical training, he joined HonorHealth as the organization's senior physician leader in 2015 and has since held leadership roles with the organization's medical staff, Scottsdale Health Partners, and the HonorHealth Board of Directors. His professional experience includes serving as the chairman of Southwest Medical Imaging, a large radiology practice that has been active in ambulatory development, practice mergers and joint ventures.Dr. Neil holds a bachelor's degree in biochemistry from the University of Kansas and graduated with honors from Washington University School of Medicine. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

In this episode we continue our conversation with Colleen Hole, Vice President of Clinical Integration in Population Health at Atrium Health, about how the Hospital at Home care model contributes to value-based care and better patient outcomes. Colleen, in our last episode we left off talking about holistic patient care in the home. Having cared for several elderly family members myself, I have seen the difference that it made for them to be in familiar surroundings versus being in the hospital. I guess home is where the heart is, right? Would you share with us the Hospital at Home Scope of services being provided?So essentially anything you could receive in a brick and mortar facility, we can do in your home. Short of an invasive procedure or surgery, obviously, we don't do that and advanced imaging like MRI and CT scan, although that technology exists, we're not quite that there yet. But you can get pretty much any medical nursing intervention that you would get in a hospital, respiratory treatments, oxygen therapy wound care, IV fluids, IV antibiotics, chest X-ray, ultrasound, I mean though that's mostly what you're going to hospital for, obviously your medications we provide all of that is provided by 24/7 virtual nursing team. That patient can hit a button and have my nurse pop up on a screen just like a call bell in a hospital. They also get two visits by our community paramedicine or mobile integrated health team, you might hear it called both things, they're in the home twice daily for anywhere from 45 minutes to an hour twice daily. That is absolutely more time than you've got a clinician in your hospital room. You also have a daily virtual visit with the provider who is on camera real time doing an assessment while the paramedic is in the home. We've got electronic stethoscope, they could listen to your heart and lungs, they write orders, and then our nursing and community paramedic team carry out those orders. We also have, just like in a in a hospital, pharmacy, care managers, social work, respiratory therapy, physical therapy, occupational therapy, behavioral health, chaplains, all of those things mostly provided virtually, which we learned how to do now after three years of COVID. The other in-home service sometimes is our therapist, our physical therapy and occupational therapist. But a good bit of their work is done just literally on camera in a virtual visit. So it's hospital level care delivered in the safety and comfort of a person's homeI didn't realize that it was such a comprehensive program. That's pretty amazing that the capabilities for that are there. I think that's definitely a good thing and can you tell me how this model enhances value-based care and what is the typical savings here?So, the purest definition I know of value is the same or better quality at a lower cost. I mean that's maybe oversimplified, but the hospital home actually does that. Our Ed visit, readmissions, mortality, all of those are lower than brick and mortar and our patient experience is higher significantly higher, not surprising probably, right? But when you have the opportunity to actually go where patients actually live, you can address some of those issues that are causing this repeat readmission. When we go to the home and we look in their pill box and it's empty or there's no food in their refrigerator or it's 100 degrees and their air conditioner is broken, you can hopefully address some of those things. Cost wise significantly less costly and there's research out there Mount Sinai has published several have, it's estimated 20% to 30% and maybe more less costly than brick and mortar hospitalization. So again if you think about the drive value how do you deliver the same or better outcomes at a lower cost. This is certainly that.You also just by being in a physical facility utilization tends to be higher. For example, you're in the...

Jana Sizemore joins Mark Reiboldt to discuss clinical co-management arrangements as an alternative alignment model for healthcare organizations and physician groups. Clinical co-management allows physician groups to align with hospitals and health systems without becoming employed or implementing a professional services agreement.   Podcast Information Follow our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review! We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.  ·        Please email us: feedback@cokergroup.com ·        Connect with us on LinkedIn: Coker Group Company Page ·        Follow us on Twitter: @cokergroup ·        Follow us on Instagram: @cokergroup ·        Follow us on Facebook: @cokerconsulting   Episode Synopsis Primarily used with surgical specialties, a hospital will partner with independent physician groups to support or grow the service line. While each situation is unique and different, Jana highlights why hospitals should consider a clinical co-management agreement, how they differ from other forms of alignment, and when to use the co-management structure. Retaining autonomy and independence is a big selling point for independent physician groups considering clinical co-management. The physicians can affect changes to the service line that would improve quality outcomes and patient care at the hospital by developing the service line and improving staff and patient satisfaction.   Extras ·        Physicians in Practice: Ways to Align and Remain Independent ·        Aligning Hospitals and Physicians with Clinical Co-Management Agreements ·        Hospital/Physician Alignment and Clinical Integration ·        Episode 102: How do you Align Provider Compensation with Health System Goals?

In this episode we learn about the Hospital at Home care model from Colleen Hole, Vice President of Clinical Integration in Population Health at Atrium Health, responsible for integrating the principles of Population Health and value-based care into clinical and operational practice.Colleen Hole, welcome to the move to value podcastWell thanks Thomas I'm really glad to be here I'm curious Colleen, how did you become interested in population health? Not to show my age but I've been at nursing for many decades and most of those years were spent in acute care in a hospital. And to be honest I think most folks in a hospital just work to get through their shift without really any visibility upstream or downstream as to what brought that patient in or what we're sending them off to. So, we often, not often, always do incredible care in that moment but it's really hard to have visibility into what else is happening in that patient's life that's making them struggle and circling back through our Ed and our hospital. And really, I could see miracles where we save lives every single day but largely in silos, but our patients don't actually live in a silo, they live everywhere else but the places that we take care of them. So about 10 years ago or so clinical integration became a thing, and I was intrigued by that because I saw it as aligning care really across the continuum. Now our focus was more internal, how do we align care within our health system, but it was about providing care like we had been doing but more about coordinating that care among silos. And I always thought gosh there's got to be more to this than just what we're doing here. And then about seven years ago here at Atrium Health we launched population health and it kind of hooked that to the drive to value. And I was lucky enough to be part of that pretty early on and really loved seeing how health systems were starting to take responsibility for what happened outside of hospitals, around food insecurity and livable safe housing etcetera and then the social determinant of health thing became a thing. So, I guess it's evolved over many decades but really excited I think where I see health systems going now with pop health.So, I know that you're involved with the Hospital at Home program can you tell me about this program as just an overview perhaps about how this concept came about?Sure so if you go back 100 years ago where there weren't brick and mortar hospitals much, many patients received what you might call hospital level care in their home. But with Hill-Burton and post-World War Two we built a whole bunch of brick and mortar across the world. But about I guess 30-35 years ago, the concept kind of came back around more in Europe and even Australia, where for various reasons health systems were starting to go back into homes to deliver hospital level care. And then here in America at Hopkins, Dr. Bruce Leff, a gerontologist, started a program there focused on the fragile elderly primarily recognizing that hospitals presented some risk to this population. So he started a small program and even today, it it's not 100 patients per day, but I think of him as the father of hospital at home if you will. And then when the pandemic hit many health systems were challenged with capacity. So it gave all programs a lift and here we are today with over 200 health systems approved for the CMS waiver which covers at full inpatient DRG, a Medicare hospital stay. So lots more to tell about that but it's kind of evolved over the past several decades, but never with the momentum that it us nowCan you tell me a little bit about and give me a timeline about the Atrium Hospital at home program and why it's been so successful?Sure so I was busy doing my population and health work, I also serve as the chief nurse executive of our very large...

As health equity initiatives play an increasingly important role in CMS programs, Medicare Advantage plans must commit to addressing social factors hindering access to care and driving members to take action to improve their health, such as scheduling a preventive care visit or completing a missed screening. Industry leaders from 4 & 5-Star plans discuss strategies to advance health equity and improve care access to achieve higher Star Ratings.   Topics include: Creating a true health equity strategy   Using a personalized approach to reaching the unreachable members Creating a trustworthy, comfortable approach to care access Navigation and scheduling Partnering with CBOs   Panelists: Elizabeth Benz, Vice President of Quality and Clinical Integration, Network Health; Gene Huang, Executive Chairman, ReferWell; Brindha Sridhar, Vice President, Customer Experience Strategy, MetroPlusHealth; Alexandria Tusek, Director, HEDIS & Data Analytics, Priority Health   Panelist Bios: https://www.sharedpurposeconnect.com/events/equity-timely-access-as-a-stars-strategy/   Bright Spots in Healthcare is hosting our first in-person event on August 24 & 25, 2023, in Boston. The Executive Roundtable Summit is a unique and transformative gathering, bringing together like-minded leaders from health plans, ACOs, health systems, hospitals, government agencies and community-based organizations for large-scale conversations that matter to the future of healthcare.   Payer & Provider Roundtable Summit brochure: https://images.magnetmail.net/images/clients/SPC_/attach/SPCEventBrochure3.pdf   Summit Registration:  https://brightspotssummit.eventbrite.com   This episode is sponsored by ReferWell ReferWell helps health plans advance health equity by scheduling underserved members for the care they need, be it medical, care gap appointments or — through your community partnerships — appointments for services like transportation assistance, nutritional counseling, mental health services and other community-based organization offerings.   -| The Health Equity Podcast Channel is made possible with support from Bayer G4A. Learn more about how Bayer G4A is advancing equity, access and sustainability at G4a.health -| This episode originally aired on February 18, 2023 on Bright Spots in Healthcare with Eric Glazer. Listen, follow and subscribe at https://healthpodcastnetwork.com/show/bright-spots-in-healthcare/

It's International Women's Day and with this in mind, today's Business of Healthcare podcast guest really requires no introduction.   I am extremely proud to feature NHS England Director for Clinical Integration (and deputy lead responsible for the delivery of the Covid vaccination programme), GP, Mum of two and former NHSE first female Medical Director for Primary Care, Dr Nikki Kanani MBE.   To say I was super excited to do this interview would be an understatement and amongst the many things we managed to cover within our relatively short chat, I was particularly focused on finding out what it's really like being Dr Nikki Kanani;  How does Nikki manage her time, day to day, in her professional, and her home life?  When did Nikki's career evolve from GP to GP and national leader?  What does being a celebrity in her field really feel like and what are the practical impacts?  When is being better good enough versus delivering the very best, across Nikki's multi-hatted portfolio?  How does she feel about her work right now?  Bearing in mind that her role has often involved overseeing the release of (sometimes not well received) policy and, particularly where the vaccination programme is concerned, potentially divisive strategy, how does Nikki deal with conflict and ensure she has ample time for self-care and access to  personal sources of support?  And of course….I had to ask about the future for PCNs!  This is a fascinating listen from a truly inspirational female leader…. enjoy!    Work with me        I'm Tara Humphrey and I'm the founder of THC Primary Care, a leading healthcare consultancy. I provide project and network management to Primary Care Networks and consulting support to clinical leads. To date, I've worked with 11 Training Hubs and supported over 50 Primary Care Networks and 3 GP Federations.  I understand and appreciate the complexity of healthcare and what it takes to deliver projects across multiple practices.       I have over 20 years of project management and business development experience across the private and public sector and have an MBA in Leadership and Management in Healthcare. I'm also published in the London Journal of Primary Care and the author of over 250 blogs.        For more weekly insights and advice sign up to my newsletter.    Improving the Business of Healthcare – One Episode at a Time         Thanks for tuning into this week's episode of the Business of Healthcare Podcast. If you enjoyed this episode, head over to Apple Podcasts to subscribe, leave your honest review, and share your favourite episodes on social media. Find us on Twitter, Instagram and LinkedIn or visit our website – THC Primary Care.   

Larry Dean, M.D., F.A.C.C., M.S.C.A.I., is an expert in general cardiology, cardiac catheterization and interventional cardiology.  Dr. Dean is Founding Director of the UW Medicine Regional Heart Center and current Medical Director of Outreach and Clinical Integration of the UW Medicine Heart Institute.  1:00 - Roll Tide2:05 - Follow the Opportunities6:35 - A retrospective of UW Cardiology10:00 - Teaching Mission11:25 - Ready for Transcatheter Aortic Valve Replacement (TAVR) 13:15 - Collaboration in the Region17:30 - Bed Capacity & Certificate of Need (CON)26:10 - Workflow Crisis30:15 - Mental Health through the diversity of practice.31:15 - PNW Cyclist36:50 - https://www.theeatingplaces.com/41:15 - The Profession of Medicine46:15 - Hippocratic Oath 51:22 - Changes in Healthcare Tensions54:30 - Investing in Balance58:00 - IT as a resourceuwheart@uw.edu

Industry leaders from MetroPlusHealth, Network Health, Priority Health and ReferWell discuss strategies to advance health equity and improve care access to achieve higher Star Ratings. As health equity initiatives play an increasingly important role in CMS programs, Medicare Advantage plans must commit to addressing social factors hindering access to care and driving members to take action to improve their health, such as scheduling a preventive care visit or completing a missed screening.  Topics include: Creating a true health equity strategy   Using a personalized approach to reaching the unreachable members Creating a trustworthy, comfortable approach to care access Navigation and scheduling Partnering with CBOs   Panelists: Elizabeth Benz, Vice President of Quality and Clinical Integration, Network Health; Gene Huang, Executive Chairman, ReferWell; Brindha Sridhar, Vice President, Customer Experience Strategy, MetroPlusHealth; Alexandria Tusek, Director, HEDIS & Data Analytics, Priority Health   Panelist Bios: https://www.sharedpurposeconnect.com/events/equity-timely-access-as-a-stars-strategy/   Bright Spots in Healthcare is hosting our first in-person event on August 24 & 25, 2023, in Boston.  The Executive Roundtable Summit is a unique and transformative gathering, bringing together like-minded leaders from health plans, ACOs, health systems, hospitals, government agencies and community-based organizations for large-scale conversations that matter to the future of healthcare.   Payer & Provider Roundtable Summit brochure:  https://images.magnetmail.net/images/clients/SPC_/attach/SPCEventBrochure3.pdf   Summit Registration:  https://brightspotssummit.eventbrite.com   This episode is sponsored by ReferWell ReferWell helps health plans advance health equity by scheduling underserved members for the care they need, be it medical, care gap appointments or — through your community partnerships — appointments for services like transportation assistance, nutritional counseling, mental health services and other community-based organization offerings.  

Dr. Jeanne Marconi is Vice President of Clinical Integration at PM Pediatric Care. After 25 years in private practice Dr. Marconi joined PM Pediatric Care to bring her innovative and out of the box thought leadership to help meet the gaps in behavioral health care delivery to children and young adults by leveraging PM's presence in 17 states and robust telehealth platform. While in practice she was at the forefront of mental health assessments and delivery of services by care managers, social workers, and psychiatric nurse practitioners through a collaborative model. Please subscribe to our podcast on apple or amazon and give us a great review. You can make suggestions for guests and topics on our website below. Thanks for listening. Follow us on social media YouTube, Instagram, WebPage The Pediatric Lounge - A Podcast taking you behind the door of the Physician's Lounge to get a deeper insight into what docs are talking about today, from the clinically profound to the wonderfully routine...and everything in between. The conversations are not intended as medical advice and the opinions expressed are solely those of the host and guest.

Wenn nichts mehr Spaß macht, alles sich fad, leer und grau anfühlt, könnte es sich um Anhedonie handeln, die Unfähigkeit, sich zu freuen. Dieser Freudlosigkeit können wir mit Achtsamkeit begegnen. **********An dieser Stelle findet ihr die Übung:00:34:03 - Übung, um die Vorstellungskraft zu stärken und die Aufmerksamkeit auf positive Momente des Alltags lenken**********Dianes und Main Huongs Empfehlungen:Fachliteratur: Anhedonia, Preclinical, Translational and Clinical Integration. Pizzagalli, D.A. (Hrsg.). (2022) Springer.Studie: Carlton, C. N., Antezana, L., Garcia, K. M., Sullivan-Toole, H., & Richey, J. A. (2022). Mindfulness-Based Stress Reduction Specifically Improves Social Anhedonia Among Adults with Chronic Stress. Affective Science, 3(1), 145-159.Studie: Craske, M. G., Meuret, A. E., Ritz, T., Treanor, M., Dour, H., & Rosenfield, D. (2019). Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia. Journal of Consulting and Clinical Psychology, 87(5), 457. **********Mehr zum Thema bei Deutschlandfunk Nova:Bewusster leben: Endlichkeit spürenAchtsamkeitstraining gegen Burn-Out - was hilft wirklich gegen den Stress?Achtsamkeit: Gut gelaunt in den Tag startenAchtsamkeit: Achtsam denkenDankbarkeit: macht achtsam**********Den Artikel zum Stück findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: Tiktok und Instagram.**********Ihr habt Anregungen, Ideen, Themenwünsche? Dann schreibt uns gern unter achtsam@deutschlandfunknova.de

Dr. Kerry Fierstein, CEO of Allied Physicians Group and Adjuvant.Health. She has been a practicing pediatrician for more than 30 years, and today also works to advocate for physician-led practices. She will moderate the panel. Dr. Gaggino has worked as a pediatrician for over 30 years on the west side of Michigan. During her career as a primary care physician, she has been privileged to care for children and adolescents and knows that their success is closely tied to mental wellness. She is the host of Pediatric Meltdown Podcast and founder of Medical Behavioral Health Solutions where you can get consultations on options for your practice. Brought to you by Allied Physician Group, Pediatrics Meltdown, and The Pediatric Lounge.Susan Sirota MD, a teacher, a leader, and - of course - a pediatrician, Dr. Sirota is one of the founding partners of Pediatric Partners and the Chairperson of the Board of Managers of PediaTrust. She's been proudly caring for children in  Highland Park, and Vernon Hills for 25 years. Chicago, Illinois Dr. Jeanne Marconi is Vice President of Clinical Integration at PM Pediatric Care. After 25 years in private practice, Dr. Marconi joined PM Pediatric Care to bring her innovative and out-of-the-box thought leadership to help meet the gaps in behavioral health care delivery to children and young adults by leveraging PM's presence in 17 states and robust telehealth platform. Dr. J. Scott Rogers, DO, FAAP   is the Vice-President of Business at Priority Care Pediatrics (PCPEDS) and an Adjunct Clinical Instructor for Kansas City University of Medicine and Biosciences. PCPEDS was founded in 2004. DrThe Wealthy Coach Podcast Hey Coaches, Practitioners & Healers! Go from 0 clients to a 6-Figure Online Biz!Listen on: Apple Podcasts Spotify Healthy Lifestyle Solutions with Maya AcostaAre you ready to upgrade your health to a new level and do so by learning from experts...Listen on: Apple Podcasts SpotifyPlease subscribe to our podcast on apple or amazon and give us a great review. You can make suggestions for guest and topics on our web site below. Thanks for listening. Follow us on social media YouTube,, Instagram, Web Page The Pediatric Lounge - A Podcast taking you behind the door of the Physician's Lounge to get a deeper insight into just what docs are talking about today, from the clinically profound to the wonderfully routine...and everything in between. The conversations are not intended as medical advice and the opinions expressed are solely those of the host and guest.

This episode features Dr. Jackie Cawley, Chief Medical Officer for Ambulatory Care and Clinical Integration at BayCare Health System. Here, she discusses vaccines, her thoughts on competition, and more.

Listen as Tariq Kahn discusses his “ah ha” moment of “I need your help”. In these three short webcasts Tariq considers how educating staff about the importance of each key player's role improves their understanding of the final goal and helps projects to be accomplished with efficiency and success. Webcast 1: Reduce Waste through Human Engagement and Investment Webcast 2: Business and Clinical Side of Health Care Webcast 3: Service Line Meetings for Successful Clinical Integration and Cost Reduction Speaker: Tariq Kahn, Materials Manager, Peri-operative Services Montefiore Medical Center

With the new term “Clinical Integration in Supply Chain” that has been embraced by many health systems throughout the country, there seems to be a little confusion regarding the actionable steps with this next level modality. You could easily say that you need more physician involvement in value analysis teams or need to add more clinicians to the teams as well. Most value analysis teams are already made up of key clinicians, including some doctors. What exactly are you going to accomplish with just adding these titles to your teams?

This episode features Dr. Robert Brenner, President of Clinical Integration & Physician Enterprise at Valley Health System. Here, he discusses what makes a good leader, the time and energy it takes to start a new hospital, how Valley Health System has been able to stay independent, and more.

This episode features Dr. Jackie Cawley, Chief Medical Officer for Ambulatory Care and Clinical Integration at BayCare Health System. Here, she discusses vaccines, her thoughts on competition, and more.

Host, Dr. John Sweetenham, associate director of Clinical Affairs at UT Southwestern Harold C. Simmons Comprehensive Cancer Center, and Dr. Sandra Kurtin, director of Advanced Practice and Clinical Integration at the University of Arizona Cancer Center, discuss the future importance of advanced practice providers to the oncology workforce and how to enhance their role in cancer research. Transcript:  Dr. John Sweetenham: Hello. I'm John Sweetenham, the associate director of Clinical Affairs at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center, and host of the ASCO Daily News podcast. Today we'll be discussing the role of advanced practice providers in oncology and their future importance to the oncology workforce.     I'm delighted to welcome our guest, who's a former colleague of mine, Dr. Sandra (Sandy) Kurtin, the director of Advanced Practice and Clinical Integration and an assistant professor of Clinical Medicine at the University of Arizona Cancer Center. Dr. Kurtin is also the president and founding board member of the Advanced Practitioner Society for Hematology and Oncology and an associate editor for the American Society of Hematology News. Sandy, it's great to renew our acquaintance and to have you on the podcast today.     Dr. Sandy Kurtin: Thank you, and I'm delighted to be here.     Dr. John Sweetenham: Before we start, I should mention that my guest and I have no conflicts of interest relating to our topic today. Full disclosures of all guests on the podcast are available on our transcripts, asco.org/podcasts. So Sandy, workforce shortages have been a concern in oncology for some time now and there has been a concern expressed in the literature and especially by ASCO probably for more than 5 years now--suggesting that the oncology workforce, or at least the physician workforce, is diminishing and we really need to be looking at new opportunities in terms of who comprises the workforce in the future.     In addition to a growing and aging population in the United States and an increasing incidence of cancer, we also see new and emerging therapies and technologies which increase the number of cancer survivors. So, it seems more important than ever that we utilize all of our oncology workforce, and particularly advanced practice providers (APPs) to therefore scope in oncology. Based on the assumption that we would expect much of that APP practice in the future to be independent practice, what do you think, Sandy, of the cancer services where APP led services can offer the best opportunity?     Dr. Sandy Kurtin: I think that one of the really remarkable things that I've come to realize—I've been doing this for 37 years—is that we do have not only a growing cancer population, but we have a population of patients that are living much longer, thankfully, with their cancer, and as a result, become more and more complicated patients that require much more specific and complex care, and it really does take a full team. And so, I think using everyone to the full scope of their licensure is really critical to maximize any team. This takes a team.     So, using the word ‘independent,' I think of that we are always collaborative as members of the interdisciplinary multidisciplinary team, but we can exceed and take the lead in a number of areas that I think are really critical given that population of patients. One of those things are symptom management clinics. I know we, in our practice, are part of the Oncology Care Model (OCM) initiative and we know that keeping people out of the ER and the urgent care settings, out of the hospital, is really critical for any practice and for patients.     And so, running symptom management clinics, same day outpatient clinics, having that same agility in an inpatient APP-supported practice is really important. There's been a lot of work overtime in survivorship clinics and continuity clinics overseeing infusion services. I know in our practice we more or less run a day hospital.     We have people there 12 hours a day and they're very sick and we're providing that level of service in an outpatient setting, granted that's an academic setting. And then there are some growing areas that are niches in genetics and benign hematology. So, I think there are a lot of opportunities that we are beginning to realize and hope to see grow going forward.     Dr. John Sweetenham: Yeah. Very interesting to hear what you say there, and a lot of those overlap with the initiatives that we're introducing UT Southwestern as well. And I'm grateful for you to pick up on the independent practice because I think obviously, we're all at our best when we are part of a team and I think your point is very well taken, of course, there are many aspects of what we do now that can be APP-led. Do you have any thoughts about procedure clinics or specific procedures where you think APPs could be taking the lead?     Dr. Sandy Kurtin: Oh, sure. So, we do, in my practice—well, I've done close to 30,000 bone marrow biopsies in my career.     Right? So, a lot. And I think that—so clearly there are areas where APPs do run procedure clinics and what I have found in doing as many as I've done is the more you do, the better you get and that's better for everybody, the patient, the sample, all of it. And it may be more efficient to have a group of people that do it regularly. Obviously, we still need to train our fellows and other colleagues, but I think that is something that is growing both in surgical oncology and medical oncology for sure.     Dr. John Sweetenham: So, those of us who advocate for expanding APP practice and expanding our APP workforce still encounter some barriers to doing that, as I'm sure that you have as well. Could you comment a little bit on that, on what you think are barriers that prevent us from having APPs reach their full potential in terms of the oncology workforce and any thoughts you have about how we can overcome those barriers?     Dr. Sandy Kurtin: Sure. So, I think probably the biggest barrier in my mind is the lack of understanding and that we are part of a team and it's the ever-looming relative value units (RVU), productivity measures, people trying to meet those metrics. And I think as we move toward value-based based care models where [it] is less driven by visit volume and more driven by outcomes for practices, it will become inevitable to have this interdisciplinary team.     And until we get to the point where if you're a physician [and] I'm working with you as your APP colleague and you're held to a certain RVU, then there's the sense of, well, if I give that to you then that takes away from me. So, rather than having internal competition, which I think is still unfortunately prevalent because we haven't moved away from that on a national level, but I think we will have too inevitably.     I think practices will begin to understand the value of bringing everyone up to their full potential, both in terms of direct patient care and all of those indirect care functions that have to happen to make a practice successful. So, we'll get there, but it's going to take some time, and that lack of understanding presents a barrier. Along with that comes some of the legislation—Medicare rules. Some of those were expanded during COVID-19 because we needed to maximize access to care. We've really tried to negotiate and advocate for keeping those expanded access to care initiatives in place post-COVID-19, even though we're not post-COVID-19, unfortunately. So, I think things are shifting, but we have a ways to go and that lack of understanding and that internal competition still presents a problem.     Dr. John Sweetenham: Yeah. Just changing gears a little, I think clinical trials, as we would recognize, are really a core part of our mission not just as academic medical centers, but as community oncology centers as well and, of course, they're crucial to our advancing patient care. And there are a number of studies, and without going into too many numbers here, there are a number of studies that have looked at the role that advanced practice providers play in clinical research, and particularly in recruiting eligible patients to clinical research.     There was one relatively recent study published in the JADPRO which just last year, which looked at APPs and I think it surveyed a number of APPs at academic centers. And 70% of these APPs said that they approach eligible patients about clinical trials, but not on a regular basis, and it seemed as though most APPs felt that they have more to offer in the space of clinical trials. What do you see as opportunities there? Again, do you think there are barriers that are preventing APPs from making a really solid contributions to clinical trial treatments and accrual and what could we do to elevate the APP role?     Dr. Sandy Kurtin: Sure. So, that study (DOI: 10.6004/jadpro.2021.12.5.2), a colleague Crista Braun-Inglis and was a collaborative effort between ASCO and ACCC and APPSHO, the Advanced Practitioner Society of Hematology Oncology—I happen to be the current president and founding board member of that—really brings to light the sense of I think comfort, really, with clinical trials. There's been, luckily, this robust, scientific discovery, new drugs approved on a regular basis. And as a result of clinical trials, every therapy we have comes as a result of clinical trials, and this is crucial for patient participation.     But I think if the majority of the people in that study that participated were—65% of them were in a community practice setting where they really tend to practice more as generalists as opposed to specialists. So, keeping abreast of all of that knowledge across tumor types, solid tumors, liquid tumors, for standard of care and understanding all the evolving science is really a challenge. So, I think we need to do better at just basic understanding of how a clinical trial is run. I actually published a recent paper on this.     How do you actually run a clinical trial? What is your role as an APP in terms of understanding the phase of the trial? How to do your attestation of adverse events. And we haven't done, I think, a good enough job in preparing our workforce to feel comfortable in taking more of a lead in that role. So, we're working on that in within APPSHO and collaboratively along with ASCO and ACCC and other organizations to really bring that level of knowledge up across the team in general, and I think that's what it's going to take.     Dr. John Sweetenham: Do you think we should all be doing more to promote APP-initiated and APP-led clinical trials? In other words, there are many questions and some of our APPs are now beginning to ask these questions very specifically about the practice or about specific areas of clinical intervention where they're really beginning to take the lead now. And again, what do you think that we can do to help promote that component rather than being a part of the overall clinical trials effort in helping to accrue patients? What do you think we need to do in terms of fostering original research questions from our APP colleagues?     Dr. Sandy Kurtin: That's a fantastic question and something—I think we lose an opportunity—I've been in academics my entire career and so I have been involved in numerous clinical trials. I've been involved in trials that have brought new drugs to market, which is one of the most rewarding things, to me, that we can do is to bring that option forward.     But I think along that way, the group of these clinicians, these APPs that are involved in the conduct of clinical trials—I know for me—sometimes understand the actual clinical management of these patients better than anybody because we tend to see them for those symptom management visits and more frequently than perhaps attendings might be able to accommodate and we can offer this enhanced knowledge. So yes, there's a trial.     This is the drug. Here's the mechanism of action. Here's how this was structured. But how do you actually do it? Right? How do you actually take this new drug and integrate it into your practice in a way that emulates the clinical trial so that you can achieve the outcomes seen in that trial.     And I think that's where APPs have an opportunity to step up and take the lead and say, is there a second question or third or fourth or fifth question in this trial where we can really look at symptom management in a broader scope, or particularly for drugs that have unique symptoms. We've seen many of those in hematology, which is my area of expertise.     Keratopathy as an example, like, what is that and what does that mean and how do we do that. Or some of the other more recent immunotherapies, and really excel in creating standards for management of these adverse events. So, I think that's an area where we could really bring things forward. Our pharmacy colleagues, obviously, also offer a lot along the lines of drug-drug interactions and all of the things that come with their expertise.     Dr. John Sweetenham: Yeah. I think you make a really great point there because certainly in one of my previous institutions for sure which had a very large kidney cancer practice, when a lot of the new agents for kidney cancer emerged, the folks at our institution who had the most expertise in recognizing and treating those toxicities were our APPs that were working with the research team.     So, I completely agree that there's a ton of opportunity there and a lot of untapped resource for the oncology community as a whole. And just closing on that theme in a way, when you look ahead over the next 5 to 10 years, how do you see the future role of APPs in the oncology workforce and what are year overall thoughts about the future? Do you feel optimistic or cautious about APP practice moving forward?     Dr. Sandy Kurtin: I'm an optimist anyway because I've been doing this for a long time and you have to be an optimist, right? So, I think that if we emerge from this COVID-19 pandemic, which we will, and we can get back to focusing on what we do best, I think the future is very bright. I think that I have witnessed a transformation in the collaborative environment and the willingness to—and this is an example of that is just having the opportunity to have this conversation—bring everybody up, because when we're all at our best [when] we do our best work for patients.     And I think as we see more APPs seeking advanced degrees and actually taking the steps that are required, it doesn't just come with a degree. You know that. You have to earn that respect by working hard, demonstrating clinical excellence and expertise, and being invited in, if you will, as a colleague. And so, it isn't something that you just are given, you have to earn it. That's true for physicians as well.   But I think then we all become better, and I actually think the future looks very bright. The science, I say, is crazy good. This is fantastic. The opportunities to prolong patients' lives just continue to get better and better, but we need to get better and better in how [we] preserve all those future treatment options by not letting any adverse event get too bad, so it limits those options going forward. So, it takes finesse and that takes the team, and I think we'll get there. I'm actually very optimistic.     Dr. John Sweetenham: Well, thanks, Sandy. It's great to end on a positive note. And thanks once again for agreeing to come on to the podcast today and for sharing some really thoughtful insights into APP practice now and in the future. And thanks also for all the work that you do both at your local level and nationally to advance the role of APPs in oncology. It's certainly recognized and greatly appreciated.     Dr. Sandy Kurtin: Thank you so much for having me.     Dr. John Sweetenham: And thank you to our listeners for your time today. If you enjoyed this episode, please take a moment to rate and review us wherever you get your podcasts.     Disclosures:   Dr. John Sweetenham:  Consulting or Advisory Role: EMA Wellness    Dr. Sandra Kurtin:  Consulting or Advisory Role: Incyte, Takeda, Abbvie/Genentech, BMS, Astra Zeneca, GSK    Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guests' statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   

Go online to PeerView.com/AGM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The orally bioavailable CDK4 and 6 inhibitors—abemaciclib, palbociclib, and ribociclib—have been established standard-of-care options in HR+/HER2- metastatic breast cancer for a while, and recently, abemaciclib was also approved in the adjuvant setting for the treatment of patients with early breast cancer (EBC) at high risk of early recurrence. This brings new hope to a group of patients with EBC who have been underserved by existing therapeutic options and have faced an unacceptably high risk of recurrence. With great progress in clinical research come questions about how to translate it into improvements in clinical practice. Which patients are/are not candidates for adjuvant CDK4 and 6 inhibition based on the recent FDA approval and updated ASCO recommendations? What is the role of Ki-67 testing in determining patient eligibility for treatment? How should risk be assessed to inform treatment selection and improve outcomes in patients with HR+/HER2- EBC? These questions and others are answered in this succinct educational activity to help make the most of this new adjuvant therapy option for the benefit of patients. Discuss the presentation, evaluation, diagnosis, staging, and stratification of early breast cancer (EBC) as well as emerging prognostic and predictive markers and factors that influence the risk of recurrence. Integrate the latest safety, efficacy, predictive/prognostic, and other clinically important data from studies investigating CDK4 and 6 inhibitor therapy and combinations in patients with HR+/HER2- EBC, including those with high-risk disease. Incorporate up-to-date guidance, multigene assays, risk assessment algorithms, and evidence-based treatment options into personalized management plans that leverage shared decision-making and multidisciplinary and interprofessional team-based approaches to optimize care for patients with HR+/HER2- EBC, including patients with high-risk disease.

Go online to PeerView.com/AGM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The orally bioavailable CDK4 and 6 inhibitors—abemaciclib, palbociclib, and ribociclib—have been established standard-of-care options in HR+/HER2- metastatic breast cancer for a while, and recently, abemaciclib was also approved in the adjuvant setting for the treatment of patients with early breast cancer (EBC) at high risk of early recurrence. This brings new hope to a group of patients with EBC who have been underserved by existing therapeutic options and have faced an unacceptably high risk of recurrence. With great progress in clinical research come questions about how to translate it into improvements in clinical practice. Which patients are/are not candidates for adjuvant CDK4 and 6 inhibition based on the recent FDA approval and updated ASCO recommendations? What is the role of Ki-67 testing in determining patient eligibility for treatment? How should risk be assessed to inform treatment selection and improve outcomes in patients with HR+/HER2- EBC? These questions and others are answered in this succinct educational activity to help make the most of this new adjuvant therapy option for the benefit of patients. Discuss the presentation, evaluation, diagnosis, staging, and stratification of early breast cancer (EBC) as well as emerging prognostic and predictive markers and factors that influence the risk of recurrence. Integrate the latest safety, efficacy, predictive/prognostic, and other clinically important data from studies investigating CDK4 and 6 inhibitor therapy and combinations in patients with HR+/HER2- EBC, including those with high-risk disease. Incorporate up-to-date guidance, multigene assays, risk assessment algorithms, and evidence-based treatment options into personalized management plans that leverage shared decision-making and multidisciplinary and interprofessional team-based approaches to optimize care for patients with HR+/HER2- EBC, including patients with high-risk disease.

Go online to PeerView.com/AGM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The orally bioavailable CDK4 and 6 inhibitors—abemaciclib, palbociclib, and ribociclib—have been established standard-of-care options in HR+/HER2- metastatic breast cancer for a while, and recently, abemaciclib was also approved in the adjuvant setting for the treatment of patients with early breast cancer (EBC) at high risk of early recurrence. This brings new hope to a group of patients with EBC who have been underserved by existing therapeutic options and have faced an unacceptably high risk of recurrence. With great progress in clinical research come questions about how to translate it into improvements in clinical practice. Which patients are/are not candidates for adjuvant CDK4 and 6 inhibition based on the recent FDA approval and updated ASCO recommendations? What is the role of Ki-67 testing in determining patient eligibility for treatment? How should risk be assessed to inform treatment selection and improve outcomes in patients with HR+/HER2- EBC? These questions and others are answered in this succinct educational activity to help make the most of this new adjuvant therapy option for the benefit of patients. Discuss the presentation, evaluation, diagnosis, staging, and stratification of early breast cancer (EBC) as well as emerging prognostic and predictive markers and factors that influence the risk of recurrence. Integrate the latest safety, efficacy, predictive/prognostic, and other clinically important data from studies investigating CDK4 and 6 inhibitor therapy and combinations in patients with HR+/HER2- EBC, including those with high-risk disease. Incorporate up-to-date guidance, multigene assays, risk assessment algorithms, and evidence-based treatment options into personalized management plans that leverage shared decision-making and multidisciplinary and interprofessional team-based approaches to optimize care for patients with HR+/HER2- EBC, including patients with high-risk disease.

Go online to PeerView.com/AGM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The orally bioavailable CDK4 and 6 inhibitors—abemaciclib, palbociclib, and ribociclib—have been established standard-of-care options in HR+/HER2- metastatic breast cancer for a while, and recently, abemaciclib was also approved in the adjuvant setting for the treatment of patients with early breast cancer (EBC) at high risk of early recurrence. This brings new hope to a group of patients with EBC who have been underserved by existing therapeutic options and have faced an unacceptably high risk of recurrence. With great progress in clinical research come questions about how to translate it into improvements in clinical practice. Which patients are/are not candidates for adjuvant CDK4 and 6 inhibition based on the recent FDA approval and updated ASCO recommendations? What is the role of Ki-67 testing in determining patient eligibility for treatment? How should risk be assessed to inform treatment selection and improve outcomes in patients with HR+/HER2- EBC? These questions and others are answered in this succinct educational activity to help make the most of this new adjuvant therapy option for the benefit of patients. Discuss the presentation, evaluation, diagnosis, staging, and stratification of early breast cancer (EBC) as well as emerging prognostic and predictive markers and factors that influence the risk of recurrence. Integrate the latest safety, efficacy, predictive/prognostic, and other clinically important data from studies investigating CDK4 and 6 inhibitor therapy and combinations in patients with HR+/HER2- EBC, including those with high-risk disease. Incorporate up-to-date guidance, multigene assays, risk assessment algorithms, and evidence-based treatment options into personalized management plans that leverage shared decision-making and multidisciplinary and interprofessional team-based approaches to optimize care for patients with HR+/HER2- EBC, including patients with high-risk disease.

Go online to PeerView.com/AGM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The orally bioavailable CDK4 and 6 inhibitors—abemaciclib, palbociclib, and ribociclib—have been established standard-of-care options in HR+/HER2- metastatic breast cancer for a while, and recently, abemaciclib was also approved in the adjuvant setting for the treatment of patients with early breast cancer (EBC) at high risk of early recurrence. This brings new hope to a group of patients with EBC who have been underserved by existing therapeutic options and have faced an unacceptably high risk of recurrence. With great progress in clinical research come questions about how to translate it into improvements in clinical practice. Which patients are/are not candidates for adjuvant CDK4 and 6 inhibition based on the recent FDA approval and updated ASCO recommendations? What is the role of Ki-67 testing in determining patient eligibility for treatment? How should risk be assessed to inform treatment selection and improve outcomes in patients with HR+/HER2- EBC? These questions and others are answered in this succinct educational activity to help make the most of this new adjuvant therapy option for the benefit of patients. Discuss the presentation, evaluation, diagnosis, staging, and stratification of early breast cancer (EBC) as well as emerging prognostic and predictive markers and factors that influence the risk of recurrence. Integrate the latest safety, efficacy, predictive/prognostic, and other clinically important data from studies investigating CDK4 and 6 inhibitor therapy and combinations in patients with HR+/HER2- EBC, including those with high-risk disease. Incorporate up-to-date guidance, multigene assays, risk assessment algorithms, and evidence-based treatment options into personalized management plans that leverage shared decision-making and multidisciplinary and interprofessional team-based approaches to optimize care for patients with HR+/HER2- EBC, including patients with high-risk disease.

Go online to PeerView.com/AGM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The orally bioavailable CDK4 and 6 inhibitors—abemaciclib, palbociclib, and ribociclib—have been established standard-of-care options in HR+/HER2- metastatic breast cancer for a while, and recently, abemaciclib was also approved in the adjuvant setting for the treatment of patients with early breast cancer (EBC) at high risk of early recurrence. This brings new hope to a group of patients with EBC who have been underserved by existing therapeutic options and have faced an unacceptably high risk of recurrence. With great progress in clinical research come questions about how to translate it into improvements in clinical practice. Which patients are/are not candidates for adjuvant CDK4 and 6 inhibition based on the recent FDA approval and updated ASCO recommendations? What is the role of Ki-67 testing in determining patient eligibility for treatment? How should risk be assessed to inform treatment selection and improve outcomes in patients with HR+/HER2- EBC? These questions and others are answered in this succinct educational activity to help make the most of this new adjuvant therapy option for the benefit of patients. Discuss the presentation, evaluation, diagnosis, staging, and stratification of early breast cancer (EBC) as well as emerging prognostic and predictive markers and factors that influence the risk of recurrence. Integrate the latest safety, efficacy, predictive/prognostic, and other clinically important data from studies investigating CDK4 and 6 inhibitor therapy and combinations in patients with HR+/HER2- EBC, including those with high-risk disease. Incorporate up-to-date guidance, multigene assays, risk assessment algorithms, and evidence-based treatment options into personalized management plans that leverage shared decision-making and multidisciplinary and interprofessional team-based approaches to optimize care for patients with HR+/HER2- EBC, including patients with high-risk disease.

This episode features Jonathan Hartmann, Director of Clinical Integration Services at Georgetown University Medical Center. Here he discusses how remote communications are improving the speed of which providers and researchers can receive information, how AI is helping physicians with diagnosing patients, and more.

This episode features Jonathan Hartmann, Director of Clinical Integration Services at Georgetown University Medical Center. Here he discusses how remote communications are improving the speed of which providers and researchers can receive information, how AI is helping physicians with diagnosing patients, and more.

Substantial opportunities exist to enhance vendor relationships to create partnerships that support more reliable supply chain operations. Achievement of improved end-to-end performance must include the elements of value and quality as compliments to cost-focused considerations. Historical wisdom often represented such elements as mutually exclusive, especially when viewed through vendor optics, but developing paradigms offer the opportunity to incorporate many, if not all desired contractual components – with active vendor partnerships.

This episode features Dr. Jackie Cawley, Chief Medical Officer for Ambulatory Care and Clinical Integration at BayCare Health System. Here, she discusses vaccines, her thoughts on competition, and more.

October is Physical Therapy Month, and this year the American Physical Therapy Association (APTA) has a new campaign. Orthopedist Dr. Mary O'Connor meets with Dr. Hadiya Green Guerrero, a senior practice specialist at APTA, and Dr. Drew Contreras, APTAs Vice President of Clinical Integration and Innovation, to discuss the #ChoosePT campaign. Dr. Green Guerrero and Dr. Contreras also share some of the reasons they became physical therapists, and explore the many benefits of PT, including its potential for addressing chronic conditions and health disparities. Dr. Contreras also shares the advice that he gave to help President Barack Obama move more, something which everyone can follow. 

October is Physical Therapy Month, and this year the American Physical Therapy Association (APTA) has a new campaign. Orthopedist Dr. Mary O'Connor meets with Dr. Hadiya Green Guerrero, a senior practice specialist at APTA, and Dr. Drew Contreras, APTAs Vice President of Clinical Integration and Innovation, to discuss the #ChoosePT campaign. Dr. Green Guerrero and Dr. Contreras also share some of the reasons they became physical therapists, and explore the many benefits of PT, including its potential for addressing chronic conditions and health disparities. Dr. Contreras also shares the advice that he gave to help President Barack Obama move more, something which everyone can follow. 

October is Physical Therapy Month, and this year the American Physical Therapy Association (APTA) has a new campaign. Orthopedist Dr. Mary O'Connor meets with Dr. Hadiya Green Guerrero, a senior practice specialist at APTA, and Dr. Drew Contreras, APTAs Vice President of Clinical Integration and Innovation, to discuss the #ChoosePT campaign. Dr. Guerrero and Dr. Green also share some of the reasons they became physical therapists, and explore the many benefits of PT, including its potential for addressing chronic conditions and health disparities. Dr. Contreras also shares the advice that he gave to help President Barack Obama move more, something which everyone can follow. 

APTA has launched a new initiative for professionals in the Physical Therapy profession, Fit for Practice.The program is designed to share content that will help professionals prioritize their own health in for focus areas:Movement, including strength and mobility.Restoration, including sleep and nutrition.Resiliency, including mental health and stress management.Practice health, including professional development and practice management.Drew Contreras - VP of Clinical Integration and Innovation highlights the program with us.He's joined by Eric Fernandez from Hyperice, a partner that helped bring the program together.

Titte “Srini” Srinivas MD, VP of Digital Development and Clinical Integration at CareDx, talk about their latest efforts in improving transplant patient outcomes by providing innovative and intelligent solutions throughout the entire patient journey.

We discussed a number of things including: 1. Valley Health's response to the COVID-19 crisis 2. How this pandemic has created an extraordinary opportunity for innovation and learning 3. The use of AI in tracking data related to pandemic infections and patients 4. How the virus has affected Dr. Brenner personally - symptoms and recovery Dr. Brenner is the President of Clinical Integration and Physician Enterprise for Valley Health System (VHS). He oversees quality and performance improvement, strategic relations and clinical service line development across VHS, as well as Valley Medical Group, Valley Home Care, ColigoCare (VHS's 600-provider Clinically Integrated Network) and Population Health. Dr. Brenner joined Valley in 2015 as SVP and Chief Physician Executive for VHS, and has led an organizational transformation from Fee-For-Service to Fee-For-Value that included the conversion to shared savings contracts and the development of ColigoCare and VHS's Population Health Department. Dr. Brenner led the creation of service lines spanning the continuum of care, the reorganization of Transitions in Care and Case Management, and the unification of quality management across VHS. Prior to joining VHS, Dr. Brenner served as Chief Medical Officer (CMO) of Summit Medical Group for nine years and, subsequently, as CMO of Summit Health Management. In those roles, he was responsible for strategic expansion; enhancement of organizational performance, patient safety and patient experience through the creation of robust population health, risk management and advocacy departments; clinical program development and advancement of clinical information technology. Prior to that position, he was a Senior Executive at Mountainside Hospital/Atlantic Health System and served as the Chairman of the Family Medicine Department. Dr. Brenner has also spent 15 years in graduate medical education, the last seven of which he served as the Family Medicine Residency Director at Mountainside Hospital/Atlantic Health System. ------ Simon Samaha, MD, MBA, is a veteran healthcare executive and entrepreneur. He is currently a Senior Advisor at Oliver Wyman and a member of its Health and Life Sciences Team. He is a recognized thought leader in provider with deep expertise in Clinical Services and Physician Enterprises. His career started as an executive (including serving as CEO at Summit Medical Group) on the provider side in both not and for profit, later joining a top global consulting firm initially as their healthcare center cluster leader (serving Europe Africa, India and Middle East) and later leading the Clinical Transformation practice. Dr. Samaha's focus is on strategic clinical transformation, assisting organization in optimizing their clinical assets and engaging their physicians in these transformation journeys. He has deep expertise in all aspects of physician organizations including M&A, VBC, network development, operational and financial optimization, and service line design and implementation. Dr. Samaha also helps lead Kentan Staffing Solutions, the healthcare division of ICS. He plays a key role in defining the client needs and is personally involved in reviewing every clinical SME.

Stephanie Halvorson MD is the Chief, Division of Hospital Medicine and an Associate Professor of Medicine at Oregon Health & Science University. She completed her medical school at the University of Minnesota and her residency and chief residency in Internal Medicine at Oregon Health & Science University. In 2005, she joined the Division of Hospital Medicine in the Department of Medicine at OHSU and in addition to her clinical responsibilities, has served as an Associate Program Director for the Internal Medicine Residency, Director of Medicine Teaching Service and Medical Director for Clinical Integration at OHSU. She is a recipient of a number of teaching awards including Faculty Award for Excellence in palliative care, the Early Career Physician Award from ACP, and David Bristow Award from the Medical School for representing ideals of a true physician, and is a member of Society of Hospital Medicine and fellow of the American College of Physicians. Dr. Stephanie Halvorson is efficient. If she has a list of errands, she will plan the route so she drives the least amount of miles and gets home in time. And yet, even she finds herself overextended at times. That's why every year, she follows the advice of a mentor and “empties her backpack”. She takes everything that she's doing out, and is very intentional about what she puts back in. Some projects go back, others might get handed off to someone else. This is an exercise in time management that removes the unnecessary to leave room for the essential. Pearls of Wisdom: 1. Be yourself. Recognize who you are instead of changing yourself to fit. That will lead you to your superpower. 2. Empty your backpack. Every year, figure out your priorities: what do you keep, what needs to go? This is time management by subtracting the unnecessary. 3. Look for a mentor that will be brutally honest with you, even if you don't want to hear it, and a mentee that will give you the comfort to be honest with them.

The 2021 Star Ratings Power Hour: Bottom-Line Impact and Strategies was recorded on June 30, 2021.In this episode, Julie Barnes, JD, Founder and Principal of Maverick Health Policy, and Kimberly Swanson, Vice President of Quality and Clinical Integration at Network Health Plan share valuable insights on the new measures and weighting, and ideas for optimizing your technology tools while implementing best practices to improve your member experience.  

Host Todd Searls and co-host Dr. Ashok Roy are joined by Shawn Rhodes, Director of Clinical Integration at Med Center Health. Together, from a provider and a health care executive point of view they take a deep dive into the current state of value-based care contracts with respect to Medicare. Their discussion focuses on their first-hand knowledge and lessons learned with physician contracting under value-based care, and challenges, especially those that relate to renegotiating employed and/or specialist contracts. The speakers also share their experiences building and motivating care teams to consistently achieve target metrics that result in better patient care. twitter.com/hashtag/HCBTNPod twitter.com/SearlsT twitter.com/caravanhealth Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Jake and Courtney welcome guest Brian Zehetner, Director of Clinical Integration at Humana, for a discussion about nutrition and integration of nutrition resources into workplace wellness programs. As Brian says in this episode, "Nutrition should be foundational to whatever experience you're trying to create for your target audience. Very few things can have as profound an impact as nutrition can have as pertains to general wellness and also the prevention and/or management of chronic conditions." 

Hosts: Alexander Nguyen and Nick DebiecGuest: Dr. Travis SmithDr. Travis Smith is a 2009 LECOM graduate and is currently the Associate Dean of Clinical Integration and Assessment at LECOM. He is also an emergency medicine specialist at St. Vincent's Medical Center in Jacksonville, Florida. Travis shares his pathway into medicine, keys to progressing from being a medical student to becoming a doctor, and his life in the emergency room as one of the LECOM healthcare heroes._________Please visit LECOM.edu for to learn more about the educational opportunities available at our institution.

This episode explores the role of community health workers in a clinical setting and the role that they play in bridging the gap between the community and health care professionals. The episode features special guest Quisha Umemba, MPH, BSN, RN, CHWI who is a Certified Diabetes Care and Education Specialist, a Certified Lifestyle Coach, and a Certified Community Health Worker Instructor. She also holds a certificate in Health Ministry from Wesley Theological Seminary. As a Diabetes Care and Education Specialist, Quisha consults with community organizations, social service agencies, government agencies, and healthcare systems to help them prevent and manage diabetes, pre-diabetes, and associated chronic diseases in their client populations.

Many industry insiders believe that health system-led ACOs are inherently disadvantaged to demonstrate value-based care in an environment where most revenue is still generated in fee-for-service. In moving to value, hospitals must contend with demand destruction on their fee-for-service lines of business as they reduce admissions, emergency department visits, and procedures. Physician-led ACOs, they argue, simply do not have this dichotomy; therefore, they have a clearer pathway to financial benefits from reducing hospital costs outside of the physician practice. This premise often appears correct as we often see “low-revenue” ACOs, typically led by physicians who mostly provide outpatient services, have better results than “high-revenue” ACOs, generally led by hospitals that provide both inpatient and outpatient services. Lisa M. Trumble, President and Chief Executive Officer at Southern New England Healthcare Organization (SOHO Health) respectfully disagrees. She believes that “Clinical Integration is the Answer” in this race to value, and she has the results to prove it!  As one of the leading CIN executives in the country, Lisa Trumble has shown how clinical integration can enhance communication between providers and improve on the outcomes and excessive costs that are commonly seen in an uncoordinated care delivery model. This week's episode features Lisa M. Trumble, the President and CEO of SOHO Health, a new ACO and CIN that is a partnership between Saint Francis Healthcare Partners and Trinity Health of New England. With 30 years of experience in health care leadership, Lisa shares powerful insights on clinical integration and challenges healthcare executives to “buckle up” on this race to value. Bookmarks: 3:45 Lisa comments on what it was like to start a new job as CEO right when the pandemic started! 6:30 Leading change during an important inflection point in the industry as it shifts towards value 6:45 The fragility of the FFS model during the throes of a pandemic 7:08 Lisa reflects on prior work in value-based transformation in Massachusetts and how that state differs from Connecticut in its commitment to health value 7:42 SOHO Health and Trinity Health of New England are committed to (and invested in) this transition to value-based care 8:15 Remaining on a FFS chassis is not sustainable.  Negotiating increases in FFS will not be tolerated in the future. (“Buckle up and look out!”) 8:45 Direct-to-Employer contracting 9:03 Partnering with physicians and creating JVs for Centers of Excellence and Bundled Payments 10:50 Hospitals needing to evaluate core business and how to reduce infrastructure cost to create a “survive-able” margin 11:09 Reducing utilization for unnecessary services and preventing leakage within a CIN 12:00 Despite reductions in inpatient services in VBC models, utilization is still growing in ambulatory surgery 12:20 Developing a bundled payment model with physicians in ASCs where financial incentives are aligned 12:50 Employers will no longer tolerate paying for surgeries that cost twice as much when performed in an inpatient setting 13:15 Value-based care is a difficult situation for health systems. At the same time you are losing business, you also have to transform and make key investments. 13:25 “If you don't commit to value-based care, you will slowly work your way out of the market and be uncompetitive. The market will find a way to figure it out with others.” 15:15 PHOs, IPAs, ACOs, and CINs all are struggling to figure out the best way pursue clinical integration 16:00 The beauty of a design of a Clinically Integrated Network is that it isn't limiting you to only one area of care delivery -- “Clinical Integration is the answer to how to perform well in a value-based environment.” 17:30 Multidisciplinary collaboration is important to providing the appropriate level of care 19:25 Lisa explains how SOHO is approaching colla...

This episode features Robert Warren, Executive Director of Patient Care Centers and Chief of Clinical Integration at Western University of Health Sciences. Here, he discusses his current biggest priorities, his best advice for emerging leaders, and more.

In part 2 of our series exploring mental health during the coronavirus pandemic, Kelly Blasko, a clinical psychologist and mobile health clinical integration lead for the Defense Health Agency Connected Health branch, discusses developments on apps to provide mental health tools for military health beneficiaries and how they’re helping users through the pandemic.  

Stony Brook University Hospital is a part of the Stony Brook University community that upholds the values and ideas of excellence for which Stony Brook has become so well-known. As the COVID-19 pandemic has changed everything for the Stony Brook Medicine team, this episode of Beyond the Expected, “The Coronavirus Effect: Medicine Response,” looks at the temporary ‘new normal' for the team's faculty, staff and leadership. We will also discuss how they have been called to rise up to the unprecedented challenges of COVID-19. These individuals are working tirelessly, together, to stop the spread of this pandemic. About the Guests Carol A. Gomes Carol Gomes is Chief Executive Officer and Chief Operating Officer of Stony Brook University Hospital and has more than 30 years' experience in the healthcare field. She has earned two Master's degrees from Stony Brook University in Management and Policy from the Harriman School of Management and Policy, Healthcare Management and Administration from the School of Allied Health Professions. Carol has served on the Malcolm Baldrige Quality Program's Board of Examiners since 1999 and teaches for the School of Health Technology and Management. She also holds certifications as a Fellow in the American College of Healthcare Executives, Certified Practitioner of Healthcare from the National Association for Healthcare Quality, and numerous certifications in laboratory sciences and management from the American Society for Clinical Pathology. Also the recipient of numerous prestigious healthcare industry awards, she mentors students pursuing careers in healthcare administration. Carol will share with us the steps she and the Stony Brook University Hospital are taking to provide the best, safest care possible in a beyond-challenging environment. Dr. Joshua D. Miller Dr. Josh Miller is Assistant Dean for Clinical Integration and Medical Director of Diabetes Care at Stony Brook Medicine. He is dual-certified in Internal Medicine and Endocrinology & Metabolism in the Department of Medicine. Living with type 1 diabetes for more than 20 years, Josh brings vast experience and empathy as he helps people with diabetes conquer the challenges of living with the disease. With most resources squarely centered now on emergency response for the COVID-19 pandemic, Josh is currently also running operations at the newly opened drive through testing site for our community members, located on the university campus. He's mobilizing, organizing and directing hospital staff in this challenging process and instructing them on how to remain safe while administering swab tests. Josh's background and strong interest in population health is an asset in this critical new role and he will share details on what's happening at our new testing facility in the P-lot parking area and why it's important.

Emily Brower is the Senior Vice President of Clinical Integration and Physician Services at Trinity Health in Michigan, a health system that includes both accountable care organizations and hospitals. In this week's episode of the ACO Show, she spoke with Joe and Josh about how clinically integrated networks can enter into ACO contracts and engage in preventive health initiatives, and how a hospital-based system balances its commitment to reducing health care costs and maintaining a sustainable business model. 

S1 Ep17: In this week's episode, we sit down with Michele Sasso, Director of Clinical Programs and Technology and Rebekah Diamond, Director of Policy and Business Relations for the Department of Accountable Care and Clinical Integration at Boston Children's Hospital. They speak about the challenges and intricacies of the ACO program and how their newly formed department seeks to put patient needs first. Find all of our show podcasts on your favorite podcast platforms. www.healthcarenowradio.com/listen/

Join us today as we speak with Rashmi Aggarwal, AVP of Clinical Integration at Newark Beth Israel Medical Center about community health innovation.

October 28, 2019 Dr. John Jay Shannon – CEO – Cook County Health Dr. John Jay Shannon Dr. Jay Shannon is the Chief Executive Officer of Cook County Health (CCH). He was appointed CEO in June 2014 after serving as the system’s Chief of Clinical Integration. Under Dr. Shannon’s leadership, CCH is continuing a transformative […]

Aimee Greeter and Toni Peck join Mark to recap their May 2019 presentation at the American Health Lawyers Association Health Care Transactions conference. They focus on new ways to drive physician engagement to help ensure that an organization realizes its clinical integration goals. Contact Information Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, or your preferred podcast provider. Like what you hear? Leave a review! Not there? Let us know! We welcome all feedback from our listeners. Please submit questions on any of the topics we discuss or questions about issues that interest you. You can also recommend topics for future episodes.  Email us: feedback@cokergroup.com Connect with us on LinkedIn: Coker Group Company Page Follow us on Twitter: @cokergroup Follow us on Instagram: @cokergroup Episode Synopsis While active physician leaders are needed more than ever, some are reticent to step into these roles – including seasoned clinical professionals and physicians newly out of training. Aimee and Toni discuss why engaging physicians is critical to the success of any organization, particularly now with the establishment of clinical integration within the industry. They discuss Coker Group’s 12-point assessment tool to differentiate between low- and active-engagement physicians and the drivers for their behaviors; interpret and use assessment data to customize one of five new approaches to improve physician engagement; delineate, track, and advance provider engagement through involvement, decision-making, and leadership; and, understand how to involve physicians in quality improvement processes to guide successful clinical integration initiatives. The views and comments of the presenters are their own and do not reflect the opinions and positions of their respective employers. Further, any comments made by attorneys are not intended to be, nor should they be construed as legal advice. Extras AHLA eProgram: 2019 Health Care Transactions Conference White Paper: Physician Engagement: A Crucial Component of a Healthy Organization Podcast: Maximizing Physician Engagement Bio: Aimee Greeter Bio: Antonia (Toni) Peck

Roy Henry, strategic analyst from University of Miami, explores how clinical integration can evolve your supply chain while discussing the value of clinical integration and how it can be measured.

In this MGMA Insider podcast, Ellis “Mac” Knight, MD, MBA, Senior Vice President, Chief Medical Officer, Coker Group and Bill Waters, Founder, Waters Healthcare Consulting, LLC, discuss how to "Leverage a Clinical Integration Model for Better Financial Management." ### As value-based reimbursements become the norm, hospitals and physician groups are finding that clinical integration can enable higher value production at the front lines of care delivery. Knight and Waters explain: *Clinical integration and how it differs from hospital–physician employment and other hospital–physician alignment models *How to Identify the industry drivers of the clinically integrated model You can hear Knight and Waters discuss this topic in greater detail on Tuesday March 5 at MGMA19 | The Financial Conference in Las Vegas. For more information, go to mgma.com/events. You can also access the entire cataloge of MGMA Insider episodes at mgma.com/podcasts

Today’s healthcare environment requires providers to find new ways to improve quality while decreasing costs. One proven approach unites healthcare providers to increase value across the care continuum through clinical integration (CI). But the challenge remains for health systems striving to drive successful CI while operating in both fee-for-service and value-based care environments.

Teresa Dail, AHRMM’s 2018 Chair, shares AHRMM’s definition of clinical integration and why a clinically integrated supply chain is important to her and her colleagues at Vanderbilt University Medical Center.

Anne Pendo, MD, Internist and Medical Director for the Experience of Care and Clinical Integration, talks with Joshua Romney, MD, Internist at Memorial Clinic about how using and continually improving patient advisories and other tools within our electronic medical record as well as resources like team huddles—allow us to close care gaps and address needs to keep our patients healthy and out of the hospital.

In this short webcast, Dena Jackson and Sophie Rutherford discuss supply chain as the hub of your organization as value analysis is transforming to clinical integration and changing the organization.

Today host Dr. Ryan Stanton talks to Dr. Christopher Russi about the clinical integration and communication among Emergency Departments including the usage of telemedicine.

With special guests Madhura Chandak Bajaj, FACHE, MSPT, RHIA, Executive Director of Clinical Integration at JPS Health Network in Fort Worth, TX, and James Montgomery, RN, BSN, Clinical Documentation Improvement Manager for JPS Health Network in Fort Worth, TX. Co-host Sharme Brodie, RN, CCDS, AHIMA Approved ICD-10-CM/PCS Trainer. To view the 2018 ACDIS Conference brochure, please click here.

I am really excited about today’s show. One of the reasons I started this podcast is because I think compliance officers learn so much from listening to other compliance officers share their experiences. Today we are going inside the structure of the ACO compliance programs for two large health systems. We will talk with their compliance officers and each of will respond to the same questions so you’ll get a really good understanding of their organizations, how they have set up their compliance programs and how they interact with governance and operational leadership. We’ll also talk about challenges they’ve encountered, one area of compliance that they are focusing on in 2017, and then their recommendations for anyone either starting or managing an ACO compliance program.  First we’ll hear from Becky Lovelace, she is the Compliance Director for Ascension Care Management Health Partners. Then we will hear from Robert Jagielski, the Compliance Director of Clinical Integration for MedProVideX, a subsidiary of Dignity Health.  This show will be perfect for you if you are just getting involved in ACO compliance and are building a program or you are currently managing an ACO compliance program and are looking for confirmation or new ideas for your program. Becky can be reached at:  becky.lovelace@ascension.org Robert can be reached at: Robert.Jagielski@DignityHealth.org  You can reach me at compliancemastermind@gmail.com  Remember to subscribe to the show! Disclaimer: On this podcast I speak only for myself and what I share are the opinions of me alone. My guests also speak for themselves only and do not represent the opinions of their firms or organizations. All content provided on this podcast is for information purposes only. Neither I or my guests make any representations as to the accuracy or completeness of any information on the podcast or in the show notes. This podcast should not be used in any legal capacity whatsoever. Please consult a qualified attorney before taking any action that could have legal implications to you or your business.  

This podcast episode has been edited from a March 2017 webinar on “Clinical Integration Strategies to Drive Value-Based Performance” originally presented in partnership with Modern Healthcare. Hosted by Dennis Butts, director of strategic solutions at Navigant, the discussion features Joseph S. Vasile, MD, MBA, president and chief executive officer of the Greater Rochester Independent Practice Association, Mark C. Shields, MD, MBA, a senior advisor at Navigant, and Matt Hussmann, director at Henry Ford Health System.

Meg Meador, NACHC Director of Clinical Integration and Education, shares information on hypertension--also known as high blood pressure--and what Community Health Centers are doing to diagnose and control hypertension in their patients. For the resources mentioned in this podcast make sure to visit https://millionhearts.hhs.gov/.

Tina Miteko chats with Helen Figge, VP of Clinical Integration for Alere ACS about the role that health IT plays in improving patient care and efficiency; data security and privacy; and how big data can impact the healthcare sector.

On the Wednesday July 24th broadcast at 10AM Pacific/1PM Eastern our special guest is physician, entrepreneur, consultant and executive coach Margaret (Maggi) Cary, MBA, MPH. For an introductory piece on Dr Cary click here. Meanwhile an overview from Dr. Cary's profile: 'Maggi is a DC based Executive and Leadership Coach and Consultant who works with both corporate and physician executives. Clients include physicians and healthcare executives at University of Maryland School of Medicine, The Mayo Clinic, University of South Florida, University of Massachusetts Medical School, University of South Florida. SupporTED coach and TEDMED Great Challenge facilitator. Maggi is also a Clinical Assistant Professor at Georgetown University School of Medicine and Director, Physician Leadership Development at the Veterans Health Administration.' We'll discuss Dr. Cary's interest in executive coaching and the important role she sees it playing in the healthcare transformational process. Given the centrality of physician leadership and the too often less that ideal social skills of some physicians expected to lead, there has been an increased emhasis on supporting the culture and organizational development shift physician are expected to champion. From volatile mix of changing regulatory, competitive and financial incentives a trusted yet objective 3rd party coach can play a key role in facilitating leadership in clinical integration, institutional change and/or outright re-invention. Learn from one of the best in the business!  

Dr. Eric B. Miller is a psychotherapist, music therapist and biofeedback therapist with experience in inpatient, outpatient, corporate and educational settings. He lectures on Music Therapy at Immaculata University and Montclair University and is a regular speaker at international conferences. Dr. Miller founded the Biofeedback Network and serves as Executive Director of non-profit organizations Expressive Therapy Concepts and Music for People. He resides in Phoenixville, Pennsylvania.   His book: Bio-Guided Music Therapy A Practitioner's Guide to the Clinical Integration of Music and Biofeedback Forewords by Joseph P. Scartelli and C. Norman Shealy 2011, Paperback: $29.95 ISBN: 978-1-84905-844-5, 9.25in x 6in, 256pp

Dr. Eric B. Miller is a psychotherapist, music therapist and biofeedback therapist with experience in inpatient, outpatient, corporate and educational settings. He lectures on Music Therapy at Immaculata University and Montclair University and is a regular speaker at international conferences. Dr. Miller founded the Biofeedback Network and serves as Executive Director of non-profit organizations Expressive Therapy Concepts and Music for People. He resides in Phoenixville, Pennsylvania.   His book: Bio-Guided Music Therapy A Practitioner's Guide to the Clinical Integration of Music and Biofeedback Forewords by Joseph P. Scartelli and C. Norman Shealy 2011, Paperback: $29.95 ISBN: 978-1-84905-844-5, 9.25in x 6in, 256pp

Thinking about creating an accountable care organization? The clinical integration of healthcare providers can be the first step, facilitating the coordination of services required for shared accountability and reward. Dr. Mark Shields, senior medical director with Advocate Physician Partners, describes the logistics of training 3,400 providers on clinical integration, the importance of the physician peer group in this effort, and the business case for the devotion of three of Advocate's 41 performance measures to smoking cessation and prevention. Dr. Shields will share Advocate's clinical integration strategy during "How To Create an ACO Framework Through Clinical Integration with Independent Physicians," a 45-minute webinar on December 1, 2010.